JUSTICE - According to the prosecutor of Marseilles, there is no test of the PIP gel on mice but a mere technical expertise on the strength of these prostheses ...Prosecutors in Marseille on Monday denied an investigating judge is about to be tested on mice the silicone gel e causing the PIP breast implants scandal , as indicated by a lawyer for the civil parties.
" This information is completely wrong . There is no such test scheduled on mice, but a simple technical expertise on the strength of these prostheses, at a cost of about 80,000 euros, not a million, "said the prosecutor of the Republic Brice Robin, belying information given by the lawyer Philippe Courtois defending more than 2,700 women plaintiffs.
Liquidated in March 2010, the company used for its PIP implants unapproved silicone gel and cheaper than officially stated.
According to Philippe Courtois, the judge in charge of the investigation opened for involuntary manslaughter and injuries is about to be tested on ten mice fraudulent gel, having obtained a budget line for this purpose.
The lawyer also mentioned a "exorbitant" cost for these tests, a million, a sum that would have been, he said, "much more useful to compensate the victims."
The discovery in November 2011 of a case of anaplastic large cell lymphoma cells, a rare type of lymphoma, in a carrier woman PIP led the French health authorities to provide preventive withdrawal but no cases have since been reported.
According to the French Agency of Medicines and Health Products 17,411 women had withdraw late December 2013 their PIP breast implants , most preventive, for a number of carriers estimated at 30,000 in France and several hundred thousand in the world.
The Agency has previously reported 74 breast cancers occurred in women carrying PIP implants, but noted that they are not "related to the peculiarities of PIP prostheses."
The main leaders of the company Poly Implant Prosthesis Var (PIP), directed by Jean-Claude Mas, were convicted at trial in another part of the deal for aggravated deception and fraud.
During the trial in Marseille in spring 2013, Jean-Claude Mas recognized the fraudulent use of this gel, but persisted in denying its harmfulness. The hearing was not allowed to decide the central question of dangerousness of the product, produced studies are quite reassuring, but had highlighted the rate of implant ruptures and "transudation" prostheses than normal. Read more
